|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Delinia
| Delinia 5980 Horton Street, Suite 470 Emeryville, CA 94608 | |
| | Year Established: | 2015 | Main Contact: | Saurabh Saha MD PhD, President & CEO | | Other Contacts: | Lijun Wu, Ph.D., Senior VP, Preclinical and Early Clinical Development Jeffrey Greve, Ph.D.,, Co-Founder & CSO
| | Company Description | Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases. Delinia’s lead program is a molecule that selectively potentiates and expands regulatory T cells (Tregs), the powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Delinia’s scientific founders and experienced executive leaders are working to advance the company’s initial programs to the clinic.
On Jan.26, 2017 Celgene and Delinia announced an agreement for the acquisition of Delinia by Celgene. Celgene will make an initial payment of $300 million, and Delinia shareholders will be eligible to receive up to an additional $475 million in milestone payments. | |
|
|
|
|
|